UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Mix-a-lot: Impulse der Mixed-Methods-Forschung für die Empirische Kulturwissenschaft

Zeitschrift für Empirische Kulturwissenschaft, 2024-06, Vol.2024 (1), p.62-89

Heibges, Maren

2024

Volltextzugriff (PDF)

Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW)

JMIR formative research, 2023-04, Vol.7, p.e41179-e41179

2023

Volltextzugriff (PDF)

"You Never Get a Second Chance": First Impressions of Physicians Depend on Their Body Posture and Gender

Frontiers in psychology, 2022-03, Vol.13, p.836157-836157

2022

Volltextzugriff (PDF)

Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of Germany

Biomedicine hub, 2022, Vol.7 (1), p.36-41

2022

Volltextzugriff (PDF)

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis

The American journal of cardiology, 2020-12, Vol.136, p.38-48

2020

Volltextzugriff (PDF)

Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics

British journal of clinical pharmacology, 2020-10, Vol.86 (10), p.1989-1999

2020

Volltextzugriff (PDF)

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis

Journal of clinical apheresis, 2020-06, Vol.35 (3), p.163-171

2020

Volltextzugriff (PDF)

Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis

Atherosclerosis. Supplements, 2019-12, Vol.40, p.17-22

2019

Volltextzugriff (PDF)

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

Journal of clinical apheresis, 2019-08, Vol.34 (4), p.423-433

2019

Volltextzugriff (PDF)

Lipoprotein(a) and mortality—a high risk relationship

Clinical research in cardiology supplements, 2019-04, Vol.14 (Suppl 1), p.13-19

2019

Volltextzugriff (PDF)

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

Pediatric nephrology (Berlin, West), 2018-07, Vol.33 (7), p.1199-1208

2018

Volltextzugriff (PDF)

Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial

Journal of exposure science & environmental epidemiology, 2017-07, Vol.27 (4), p.444-450

2017

Volltextzugriff (PDF)

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Clinical research in cardiology supplements, 2017-03, Vol.12 (Suppl 1), p.38-43

2017

Volltextzugriff (PDF)

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Arteriosclerosis, thrombosis, and vascular biology, 2016-09, Vol.36 (9), p.2019

2016

Volltextzugriff (PDF)

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial

Atherosclerosis. Supplements, 2015-05, Vol.18, p.35-40

2015

Volltextzugriff (PDF)

Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study

Clinical research in cardiology supplements, 2015-04, Vol.10 (Suppl 1), p.46-50

2015

Volltextzugriff (PDF)

(K)information: Gamete Donation and Kinship Knowledge in Germany and Britain

Klotz, Maren

1. Aufl., 2014

Volltextzugriff (PDF)

Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – Perspectives for immunoadsorption

Atherosclerosis. Supplements, 2013-01, Vol.14 (1), p.161-165

2013

Volltextzugriff (PDF)

Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis

Journal of clinical apheresis, 2012, Vol.27 (2), p.99-105

2012

Volltextzugriff (PDF)

Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis

Journal of Clinical Apheresis, 2012, Vol.27 (2), p.99-105

2012

Volltextzugriff (PDF)

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

Therapeutic apheresis and dialysis, 2010-06, Vol.14 (3), p.276-286

2010

Volltextzugriff (PDF)

Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy

HNO, 2010-05, Vol.58 (5), p.445-451

2010

Volltextzugriff (PDF)

Rheopheresis for sudden sensorineural hearing loss

Atherosclerosis. Supplement (Amsterdam), 2009-12, Vol.10 (5), p.102-106

2009

Volltextzugriff (PDF)

Plasma exchange and immunoadsorption for autoimmune neurologic diseases – current guidelines and future perspectives

Atherosclerosis. Supplement (Amsterdam), 2009-12, Vol.10 (5), p.129-132

2009

Volltextzugriff (PDF)

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

European archives of oto-rhino-laryngology, 2009-07, Vol.266 (7), p.943-953

2009

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(39)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mix-a-lot: Impulse der Mixed-Methods-Forschung für die Empirische Kulturwissenschaft

Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW)

"You Never Get a Second Chance": First Impressions of Physicians Depend on Their Body Posture and Gender

Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of Germany

Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis

Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve—A sibling‐controlled case study on the efficacy of lipoprotein apheresis

Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis

Lipoprotein(a) and mortality—a high risk relationship

Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity

Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial

Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial

Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study

(K)information: Gamete Donation and Kinship Knowledge in Germany and Britain

Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies – Perspectives for immunoadsorption

Long‐term strategies for the treatment of Refsum's disease using therapeutic apheresis

Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy

Rheopheresis for sudden sensorineural hearing loss

Plasma exchange and immunoadsorption for autoimmune neurologic diseases – current guidelines and future perspectives

Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial

Suchergebnisse filtern